Cell studies of lung adenocarcinoma have revealed that estrogen can induce overexpression of CXCR4, which could support tumor growth and metastasis through the CXCL12/CXCR4 pathway (Figure 2A) [147]. This evidence concerns the gene CXCL12 and lung adenocarcinoma.